Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-23-001446

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 10, 2023 50.8M sh
Long Term Debt Q2 2023 · Jun 30, 2023 $103.13K
Long Term Debt Q2 2023 · Dec 31, 2022 $101.35K
Short Term Debt Q2 2023 · Jun 30, 2023 $129.33K
Short Term Debt Q2 2023 · Dec 31, 2022 $126K
Stockholders Equity Q2 2023 · Jun 30, 2023 −$193.56K
Stockholders Equity Q2 2023 · Dec 31, 2022 −$147K
Current Liabilities Q2 2023 · Jun 30, 2023 $212.94K
Current Liabilities Q2 2023 · Dec 31, 2022 $173.07K
Total Liabilities Q2 2023 · Jun 30, 2023 $212.94K
Total Liabilities Q2 2023 · Dec 31, 2022 $173.01K
Current Assets Q2 2023 · Jun 30, 2023 $144
Current Assets Q2 2023 · Dec 31, 2022 $4.79K
Total Assets Q2 2023 · Jun 30, 2023 $16.01K
Total Assets Q2 2023 · Dec 31, 2022 $22.68K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$66.21K
Sga Expense Q2 2023 · Jun 30, 2022 $14.53K
Sga Expense Q2 2023 · Jun 30, 2022 $67.57K
Net Income Q2 2023 · Jun 30, 2022 −$15.51K
Net Income Q2 2023 · Mar 31, 2022 −$54.04K
Operating Income Q2 2023 · Jun 30, 2022 −$14.53K
Operating Income Q2 2023 · Jun 30, 2022 −$67.57K